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The assessment of behavioral changes produced by prenatal or early postnatal exposure to
potentially noxious agents requires both the designing of ad hoc tests and the adaptation of tests
for adult animals to the characteristics of successive developmental stages. The experience in
designing tests is still more limited than in the adaptation of tests, but several tests have already
proven their usefulness; some examples are the suckling test, the homing test, and evaluations of
dam-pup and pup-pup interactions. Functional observational batteries can exploit the development
at specified postnatal ages of several reflexes and responses that are absent at birth in altricial
rodent species with a short pregnancy such as the rat and the mouse. In neonates, the assessment
of early treatment effects can rely not only on deviations from normal responding but also on
changes in the time of appearance of otherwise normal response patterns. The same applies to
other end points such as responses to pain and various types of spontaneous motor/exploratory
activities, including reactivity to a variety of drug challenges that can provide information on the
regulatory systems whose development may be affected by early treatments. In particular, the
analysis of ontogenetic dissociations (i.e., differential early treatment effects depending jointly on
developmental stage at the time of exposure, age of testing, and response end point) can be of
considerable value in the study of treatments' mechanisms of action. Overall, it appears that
behavioral teratological assessments can be effectively used both proactively, i.e., in risk assessment
prior to any human exposure, and reactively. In the latter case, these assessments could have
special value in the face of agents suspected to produce borderline changes in developing
humans, whose innocuousness or noxiousness can be difficult to establish in the absence of hard
evidence of teratogenicity. Environ Health Perspect 104(Suppl 2):285-298 (1996)
Key words: behavioral teratology, functional observational batteries, pain reactivity,
motor/exploratory activities, methylmercury, ethanol, benzodiazepines, ozone (03), rat, mouse
Introduction
Considerable progress has been made exposure to a physical or chemical agent
over the past two decades in the validity produces significant changes in neuro-
assessment of a variety of response end behavioral development [for reviews
points in experimental behavioral teratol- of methods and results, see (1-9); for
ogy, i.e., in studies that are aimed at proceedings of ad hoc meetings, see
verifying whether prenatal or postnatal (10-19)].
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A first distinction that needs to be made
is that behavioral teratology assessments
must often be performed with different
background information, under different
conditions, and sometimes with different
goals, depending on the agent considered.
In the case ofpharmaceutical drugs, for
example, the information on biological
effects and mechanisms ofaction, body bur-
den, and other important properties is gen-
erally much more extensive than in the case
of industrial chemicals. Moreover, in the
case ofmedicines the routine routes ofexpo-
sure (po or ip) can generally suffice in most
investigations, and negative results are only
moderately useful; in the case ofindustrial
agents, inhalation or percutaneous exposure
often need to be considered, and negative
and positive results are equally useful (20).
Since the early work in behavioral
teratology (21), economical test methods
have made a substantial contribution to risk
assessment; in addition, they have often
provided information that can be readily
translated into useful working hypotheses
concerning the significance and the nature
of the effects observed, which is essential
for deciding whether higher-tier studies are
necessary. Moreover, these methods have
played a major role in collaborative studies
aimed either at checking the replicability of
the results by experiments performed in
different laboratories under identical con-
ditions (22) or at widening the range of
assessments after a specified treatment by
subdividing the test burden between differ-
ent laboratories (23).
Behavioral teratology covers a very
broad area that includes at one end the
study ofbehavioral changes produced by
treatments whose teratogenic effects are
clearly documented by neuropathological
assessments, as is the case with quite dif-
ferent agents such as methylmercury
(MM), methylazoxymethanol (MAM), and
ethanol. Even in these extreme cases, animal
behavior studies can play an essential role in
the detection and definition ofchanges pro-
duced by exposures to doses or concentra-
tions whose effects are below the threshold
ofneuropathological methods. In humans,
this applies to children exposed either in
uteroto low doses ofethanol (24,25) or pre-
natally and postnatally to low doses oflead
(26). In both instances, human and animal
data have been shown to be in good agree-
mentwith each other (27,28).
At the opposite end, behavioral teratol-
ogy studies are essential to assess possible
risks created by exposures to agents that do
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not have a substantial teratogenic potential
as assessed by the use ofsomatic end points.
The continuing discussion on the terato-
genic potential ofdrugs such as some ofthe
antiepileptics and anxiolytics shows that the
distinction between teratogenic and nonter-
atogenic agents cannot be a sharp one;
however, there are considerable differences
(both qualitative and quantitative) between
the CNS damage produced by prenatal
exposure to these drugs and that produced
by agents such as MM, MAM, and ethanol
(at high doses). In addition, information on
the short- and long-term biochemical
effects produced by agents ofboth types is
not readily amenable to an interpretation in
the absence ofbehavioral assessments or
when negative behavioral data or minimal
changes are found after treatments that pro-
duce considerable CNS changes [see (29)
for ethanol; (30) for parathion; (31) for
methyl demeton (Meta-Systox)].
Essentially, behavioral investigations
must be sufficiently extensive and specific
to assess the meaning ofobserved correla-
tions or, at least, to help identify the mech-
anisms that induce a behavioral expression
ofa given CNS change in some situations,
but not in others. For example, the dose-
dependent increase in preweaning locomo-
tor activity observed in rats after prenatal
anticonvulsant (phenytoin) treatment when
using a square open field failed to occur in
the same laboratory when using a circular
field (32). Neonatal antidepressant (clomi-
pramine) treatment resulted in open-field
hyperactivity at the adult stage, whereas
activity in a closed chamber was not
affected; this suggested that hyperreactivity
to mild stress was the cause ofthe former
change (33). In the case of haloperidol
treatment on postnatal days 4 to 21, which
is known to produce considerable effects on
CNS dopaminergic mechanisms, mice did
not show activity changes in a photocell
activity cage, in a circular alley, and in an
operant chamber. However, activity was
significantly increased in apresumably more
stressful situation (the open field), but only
in 4 out of 12 combinations of animal
strain, age, and time oftesting (34). These
examples ofcomplex interaction profiles
should not be construed as an obstacle to
the use ofsimple and economical assessment
procedures. The experimenter, however,
should be aware ofthe frequent occurrence
ofsuch interactions so as to understand the
risk offalse negatives and false positives and
to be able to decide whether more complex
and expensive higher tier assessments are a
real need or, vice versa, a useless luxury.
The emphasis on the need for adequate
behavioral investigation does not mean that
any deviation from the behavioral profile of
control animals is to be interpreted as a sign
ofpathology (see section "Pain Reactivity
and Analgesic Drug Effects" for some indi-
cations on response variation produced by a
variety ofearly influences). Specifically, sev-
eral types ofisolated behavioral changes can
be essentially neutral with respect to ade-
quate functioning ofhomeostatic processes;
this, forexample, is likely to be the casewith
changes in activity levels when the scores of
all treated subjects remain within the range
ofthe control population, and other types
ofchanges are consistently absent. At the
present state ofthe art, no rule ofthumb is
available to separate the normal from the
pathological in borderline cases; therefore,
any reproducible behavioral change ofless
than negligible size should be taken as a
warning that the agent causing it may
require a more thorough assessment.
The survey ofeconomical test methods
will be preceded by some considerations
concerning inference strategies (particularly
those that exploit response and age dissoci-
ations of treatment effects) and research
goals in relation to available resources.
Inference Strategies, Research
Goals, and Resources
In behavioral teratology studies, the
expectancy is that different effects may be
produced depending on when exposure
occurs during development. Equally
important is the fact that even studies
using simple designs and economical test
methods can often make an effective use of
several types of contrasts in the effects'
profiles, without a substantial increase of
the test burden. A first type of contrast is
that between responses which are modified,
or not modified after a particular treat-
ment; such contrasts often provide useful
preliminary information on the treat-
ments' mechanisms of action. A second
type of contrast is that between presence
or absence of a given response change
depending on the age at the time oftesting
either during the treatment (ifpostnatal or
combined prenatal and postnatal) or after
treatment discontinuation. Contrasts of
this kind allow the experimenter to com-
pare the trend over time of treatment
effects with the developmental pace of
specified response systems; this provides
information on the relative vulnerability of
various regulatory mechanisms with differ-
ent maturational rates, including recovery
or compensation processes.
Additional useful contrasts can emerge
from the analysis ofpharmacological reac-
tivity as assessed by appropriate drug probes
or challenges. These contrasts can provide
fairly specific information on neural regula-
tory mechanisms that are affected or spared,
particularly when response and age variables
turn out to play a role in determining
whether reactivity to a particular agent is
affectedbyan earlytreatment.
Some of the effects observed in devel-
oping mice after prenatal benzodiazepine
treatment [oxazepam, 15 mg/kg po twice
daily to the dam on pregnancy days 12-17;
(35)] can be exploited to show the informa-
tive value ofthe contrasts so far mentioned.
In fact, the pups showed a substantial
reduction ofopen-field activity and response
to amphetamine at 2 weeks ofage, which
was probably not due to the slight and tran-
sient retardation ofsomatic and neurobe-
havioral development produced by the
treatment. At 3 weeks ofage, activity and
amphetamine reactivity were indistinguish-
able from those of the controls; in addi-
tion, the maturation of both habituation
and hyperactivity response to an antimus-
carinic (scopolamine) took place normally.
These contrasts suggested a selective and
transient effect on the development of
monoaminergic regulatory mechanisms,
which was further supported by the delayed
appearance of morphine hyperactivity in
the absence ofchanges in pain sensitivity or
morphine analgesia [for additional bio-
chemical and behavioral data that favor this
interpretation, see (36)].
While the additional information
provided by subsequent higher tier studies
cannot be discussed here, this example
confirms that a heavy test burden is not a
qua non to combine risk assessment and a
preliminary evaluation oftreatments' mech-
anisms of action. In the case of benzodi-
azepines, information on the latter point
turned out to be of potential value when
recent data showed borderline neuropsy-
chological deficits in children exposed pre-
natally to these agents (37).
As concerns the choice of an appropri-
ate strategy in behavioral teratologystudies,
two factors must be considered jointly, i.e.,
the goals ofa particular project and the size
and type of available resources. On one
hand, reactive studies concerning agents
for which human data are already available
(as was the case when animal studies on the
effects of MM and lead were started) are
best focused on end points that correspond
as closely as possible to the profile ofthe
effects observed (orsuspected) in humans.
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On the other hand, proactive studies
concerning agents without a previous his-
tory ofhuman exposure (or for which reli-
able data concerning possible effects in
exposed humans are notyet available) must
use tests that can pick up a wide variety of
different effects at successive developmental
stages. In general, these tests include an
observational battery assessing postnatal
neurobehavioral development, a simple
activity test administered at successive devel-
opmental stages that are characterized by
different response patterns, and one or
more additional economical tests concern-
ing end points with broad functional
significance, such as pain reactivity and
analgesic drug responses.
Subsequent decisions concern the
choice ofone or the other version ofa test,
which can be strongly influenced by the
resources available. Inparticular, automated
and nonautomated versions ofany given
test should be carefullyweighed on the bal-
ance ofpotential advantages and disadvan-
tages. In fact, automated tests can reduce
the workload by one or more orders of
magnitude and can also reduce the load of
experimenter biases. (These biases, it should
be noted, can never be entirely eliminated;
consider, forexample, the different amounts
ofstress produced by different handling
styles, which can influence the animal's
behavioral performances.) On the other
hand, tests relying on direct observation (or,
preferably, on the scoring ofvideorecord-
ings) can provide information on a wider
range ofresponse end points than auto-
mated tests. This can allow theexperimenter
to pick up effects not recorded by an auto-
mated apparatus, identifying differences
between the profiles ofdifferent treatments
which may have similar effects on responses
that can be automatically recorded (e.g., an
overall increase or decrease oflocomotor
activity). At this point, the availability of
either hard currency for the purchase of
automated apparatus or low-cost manpower
with adequate technical education (the
simultaneous availability ofboth being the
exception rather than the rule) can tip the
balance toward the use ofeither automated
ornonautomated tests.
When access to automated apparatus is
limited and heavy reliance is made-on
trained observers (see section "Spontaneous
Motor Activities" for specific guidelines),
the following minimal requirements for
the operation of a behavioral teratology
laboratory need to be fulfilled. The first
and foremost requirement is an adequate
small animal maintenance facility with
internationally accepted standards of air
quality, temperature, and humidity control.
Since the same conditions must be guaran-
teed in testing rooms, this is likelyto be the
most expensive requirement with respect
both to investment and to operating costs.
Additional requirements are a small
shop for building, maintaining, and modi-
fying a simple apparatus, one or more
videorecording units, and one or more
PCs, depending on the size ofthe research
activity. PCs capacities are best exploited
when the machines are used both for statis-
tical analyses, relying on the highly effec-
tive software now available and on expert
advice (so as to avoid the all-too-frequent
statistical monstrosities), and for processing
the input from manually operated key-
boards used to score response events,
relying on updated versions ofadhocsoft-
ware, such asThe Observer (38).
In the present overview, the space
devoted to the description ofthe various
tests has been limited as far as possible in
order to assign more space to conditions of
use, type ofinformation expected, test limi-
tations, and possible biases, induding some
ofthe more important (and sometimes
unavoidable) biases in data analysis. This is
to encourage readers, who can look else-
where for more technical details, to adopt a
critical and self-critical attitude, the only
effective protection against those traps and




The rat and the mouse are altricial species,
that is, the pups are born in a highly
immature condition after a short preg-
nancy (18-22 days, depending on species
and strain). At birth, the eyes and ears are
closed, the pup is able to crawl, and to get
attached to a nipple and to suckle, while it
needs close body contact with the mother
for purposes ofthermoregulation. Several
reflexes and responses appear at successive
postnatal stages in parallel with somatic
changes, progressively increasing the pup's
sensory and motor capabilities and, after-
wards (particularly after eye opening around
the end ofthe second postnatal week), its
ability to procure food and-fluid.-Weaning
in laboratory breeding units is performed at
a fixed time after birth, generally at the end
ofthethirdpostnatalweek.
The time of occurrence ofspecified
somaticchanges andthe time offirstappear-
ance and subsequent complete maturation
ofvarious reflexes and responses show a
remarkable regularity. This provides the
experimenter with an effective tool to assess
whether somatic and neurobehavioral devel-
opment is modified byprenatal and/orearly
postnatal treatment.
GeneralIndications
Any assessment ofearly treatment effects,
such as those illustrated in this and subse-
quent sections, should attempt to mini-
mize biases in design and data analysis (to
be mentioned later). It should collect ade-
quate information both on maternal toxic-
ity (induding reproductive end points) and
on somatic end points ofoffspring devel-
opment, in addition to those included in
test batteries for postnatal neurobehavioral
assessment (22).
Possible confounding variables must be
adequately controlled. As concerns effects
on the dam, for example, the experimenter
can obtain useful information by simple
measurements offood and water consump-
tion in addition to measurements ofbody
weight, as has been shown byrecent data on
gestational ozone (O3) exposure (40); subse-
quently, pair-fed (yoked) controlgroups may
have to be used ifa treatment has marked
effects onmatemal foodorwaterintake.
In addition, cross-fostering procedures
aimed at controlling for postnatal maternal
effects are a qua non after prenatal treat-
ments (6,35,41,42). Most studies use uni-
directional fostering ofboth control and
treated litters to untreated dams, eliminat-
ing postnatal maternal effects such as those
produced by changes in maternal functions
(e.g., milk production) or behavior, but not
allowing the experimenter to know whether
or not these effects might have occurred.
Some cues to understanding the loss of
information that can occur with any cross-
fostering procedure were obtained with a
complex design in which prenatal benzodi-
azepine treatment was followed by nursing
ofcontrol and treated litters by either their
own dams, different dams of the same
group, ordams ofthe othergroup [(43); see
in (41) a response model analysis for cross-
fostering studies based on comparisons
between different fosteringprocedures in an
experimentwithprenatal MM treatments].
The most commonly employed end
points and their--respective.developmental
time tables are essentially the same in rats
and in mice. The end points illustrated
belowhave been used in mice byourgroup
for several years and are based on the
well-known Fox battery (44) with a few
modifications and additions; equivalent
illustrations concerning the rat can be
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readily found in the literature (2,9).
Experiments performed in mice indicate
that the end points in question are
adequate to reveal both acceleration and
retardation as a result of early treatment
conditions (45,46). Accelerated develop-
ment of reflexes and responses has also
been shown in rats after early treatments
with antidepressants (47), cocaine (48),
and naloxone (49).
In most behavioral teratology studies,
the experimenter questions a) whether
treated animals are significantly retarded
relative to their appropriate controls;
b) whether neurobehavioral retardation, if
any, is specific or is associated with signi-
ficant changes in somatic development
(such as reduced weight at birth, slowing of
postnatal weight gain, delayed ear and eye
opening, or other indications ofovert toxi-
city); and c) whether the retardation is
selective or widespread, i.e., involving a
limited spectrum ofreflexes and responses
or awide varietyofend points.
With respect to the question in b, study
designs should allow calculation of
dose-response functions. For example, a
prenatal sulfur dioxide (SO2) inhalation
study (50) has shown neurobehavioral
impairment in mice at both 32 and 64
ppm, but only the latter concentration
reduced pup weight at birth.
Most simple somatic and neurobehav-
ioral end points lend themselves to ordinal
scoring. To escape the problem of litter
confounding, and to make an effective use
ofthe available experimental animals when
several tests are planned, only one animal
(or at most one male and one female) from
each litter is assigned to each test. With
this procedure, the litter random factor and
the subject random factor become one and
the same thing, eliminating a dangerous
bias that is difficult to handle in the case of
nonparametric data and greatly simplifying
data analysis (42).
TestingMicebytheFoxScale
This scale has been designed to include a
number ofend points that are representa-
tive ofvarious components of neural and
behavioral development in the first post-
natal weeks, without imposing an excessive
test burden on either the pup or the experi-
menter (44). The description given below
represents a slightly modified version of
the original scale to include some additional
measures (strong and weak tactile stimula-
tion tests) (35).
The most common procedure is to test
each animal daily to avoid time lags in the
detection of a maturational event. How-
ever, little is known about the effects of
different handling and testing burdens on
subsequent maturation of the various
reflexes and responses, although handling is
recognized as a crucial variable.
In the list that follows, the postnatal ages
at which a reflex or response first appears
and subsequently shows complete matura-
tion (i.e., aduldike characteristics) have been
intentionally omitted [for representative
illustrations ofthe absence or presence ofa
delay in postnatal neurobehavioral develop-
ment after prenatal 03 or benzodiazepine
exposure, respectively, see (40,51)]. In fact,
it appears essential that each experimenter
establish and repeatedly verify control base-
lines specific for the conditions under
which thework is conducted, including ani-
mal strain, types of control treatments
(depending on exposure schedules), and
scoring system adopted (see above). In addi-
tion to assessing the neurobehavioral end
points indicated below, it is also essential to
perform a parallel assessment ofsomatic
developmental end points, including at least
body weight gain and time ofeye opening,
ear opening, and incisor eruption. These
neurobehavioral end points ofthe Fox Scale
are as follows: a) righting reflex-pup
returns to its feet when placed on its back;
b) cliffaversion-pup withdraws from the
edge of a flat surface when its snout and
forepaws are placed over the cliff; c) fore-
limb and hindlimb stick grasp reflex-pup
grasps the shaft ofa toothpick when it is
touched to the palm ofeach paw; d) vib-
rissa placing reflex-pup places its forepaw
on a cotton swab stroked across its vibrissae;
e) level or vertical screen test-pup holds
onto a wire mesh (5x5 mm) when dragged
across it horizontally orverticallyby the tail;
f) screen climbing test-pup climbs up the
vertical screen using both fore- and hind-
paws; g) pole grasping-pup grips awooden
pencil with its forepaws; h) auditory startle
response-pup shows a whole-body startle
response when a loud clap of the hands
occurs less then 10 cm away; and i) strong
and weak tactile stimulation tests-a head-
turning response is triggered by the appli-
cation oftactile stimuli (von Frey hairs of
0.35 or 0.05 g) in the perioral area on both
sides ofthe head.
No attempt can be made here to review
the ample literature concerning the effects
ofvarious early treatments on postnatal
neurobehavioral development as assessed
by functional observational batteries like
the one illustrated above. One problem is
that batteries with more than a few end
points, while yielding consistent results
in the same laboratory over an extended
period of time, have apparently not been
included in interlaboratorycomparisons.
As concerns other problems, one can
mention the differences in treatment
effects between strains ofthe same species.
In one study, phenobarbital treatment on
days 10 to 16 of gestation delayed post-
natal sensory-motor development in mice
of the DBA strain, whereas drug-exposed
mice of the C57BL/6J strain were unaf-
fected or slightly quicker in attaining
mature responses in some tests (52). The
considerable strain difference in response
to treatment was also confirmed by the fact
that only the DBA mice developed hyper-
activity (up to three times the control level
at 18 days); in addition, the profile of
changes in uptake ofneurotransmitters by
cerebral cultures established with tissue
removed shortly after the end ofprenatal
treatment differed markedly between the
two strains.
OtherTest
A variety ofother tests that have been used
to assess the pup's neurobehavioral capabili-
ties at successive developmental stages can-
not be described and evaluated here in any
detail; these tests are often aimed at a more
thorough evaluation of maturation phe-
nomena that are subjected to quick and
approximate assessment in batteries like the
Fox scale. This applies, for example, to con-
ventional assessments ofmotor coordination
such as the rotarod test, which has a long
tradition of use in pharmacology-toxicol-
ogy, as well as to assessments of startle
responses and startle habituation, which
were included in the Collaborative Behavior
Teratology Study (22) [for a review of
reflexive measures, see (53)].
Other tests of quite different types
have proven useful, such as the swimming
test for which detailed normative data at
successive ages are available (9), as well as
various assessments of seizure sensitivity
and thermoregulatory responses; the latter
tests are clearly described in any manual
ofpharmacological methods. As concerns
thermoregulation, it is worth underlining
that the value of conventional tempera-
ture measurements, including responses to
drugs that lower or raise body tempera-
ture, can acquire greater functional value
when accompanied by simple tests of
thermotactic behavior. For example, the
finding of retarded development of ther-
moregulation after prenatal alcohol expo-
sure (54) was strengthened by the finding
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that alcohol-exposed pups moved closer to
the warm end of a thermocline than did
control pups; their body temperature, how-
ever, did not rise concurrently (55).
Still other tests cannot claim the
renown created by extensive use, but two
ofthem deserve a briefdescription because
they are quite economical and are appar-
ently able to provide information at least
somewhat different from that obtained by
the tests so far discussed.
Suckling Test. This procedure has been
extensively used in rats for a variety of
developmental psychopharmacological
assessments (56); more recently, it has been
used in mice in order to assess the effects of
a previous NGF treatment, induding those
on psychopharmacological reactivity (57).
The test can be performed at different ages
after birth and uses the anesthetized pup's
own dam in order to assess the responses to
the suckling stimulus; these indude attach-
ment to the nipple and several other behav-
iors such as paddling with forelimbs,
treading with hindlimbs, nipple shifting,
and displacing asibling from anipple.
Homing Test. This test exploits the
strong tendency of the immature pup to
maintain body contact with the dam and
the siblings, which requires adequate sen-
sory (olfactory) and motor capabilities as
well as the associative and discriminative
capabilities that allow the pup to become
imprinted by the mother's odor, to remem-
ber it, and to recognize it among others. In
aversion evolved for 10-day-old mice (51),
the pup is placed at one end ofa rectangu-
lar arena (36x22.5 cm) with a wire mesh
floor and a goal area at the opposite end
(14x22.5 cm). Shavings from the home
litter are evenly spread under the floor of
the latter area. The score is the time taken
by the pup to place both forelimbs above
the goal area. In the version most often
used in rats, the pup is placed on the divide
between the areas over home and clean




Appropriate adaptive responses to painful
stimuli are a vital part ofthe organism's
repertoire and lend themselves to assess-
ment by simple and reliable methods such
as the tail flick test, the hot plate test, and
modified versions for neonates (e.g., the
tail immersion test). In second-tier and
higher behavioral teratology studies, ifnot
in first-tier studies, any evaluation oftreat-
ment effects that does not indude this area
ofassessment must be considered as incom-
plete. This is an important notation since in
some countries the use ofany test involv-
ing even moderate pain and stress is subject
to adhocauthorization forethical reasons; in
otherwords, these tests cannot be performed
unless they are supported by a strong ratio-
nale whose validity is acknowledged by the
regulatory authority. On the other hand,
appropriate versions oftitration schedules,
which are aimed at assessing aversive thresh-
oldswhile the animal maintains control over
the magnitude ofthe stimulus and therefore
minimizes pain and stress (60,61), have
apparently not been evolved for application
to immaturesubjects.
The tail flick test measures the latency
ofthe flick response to a thermal stimulus
focused on the animal's tail. The test
requires restraint ofthe animal, but such
restraint need not to be a drastic one.
The hot plate test usually measures the
latency to the first paw-licking response
after the rat or mouse is placed on a metal
plate with temperature maintained at a
constant level. The temperature used is
generally around 55°C to ensure that all
animals experience moderate pain, but not
more intense pain.
The behavioral response measured in
the hot plate test, being obviously more
elaborate than the tail flick end point, is
highly sensitive to a variety ofinfluences,
particularly experience factors. In anyevent,
exposure to any painful stimulus, as shown
by the literature, has both short- and long-
term effects on responses to the same and to
other painful stimuli. This is often in the
direction ofreduced pain reactivity, which,
depending jointly on organismic, exposure,
and time factors, can be mediated more by
opioid or more by non-opioid (particularly
cholinergic) mechanisms (see below for an
example of differential early treatment
effects on these two types ofanalgesia).
Therefore, experimental protocols,
including sources ofexperimental animals,
must be highly standardized to avoid avari-
ety ofpossible biases such as those that may
be produced by early rearing variables and
other' environmental influences besides the
well-known effects oforganismic variables.
(In most analgesia tests, for example, male
rats tend to be less reactive than females to
pain and to display significantly greater
magnitudes ofmorphine analgesia.) In fact,
pain reactivity (including analgesic drug
responses) shows considerable developmen-
tal plasticity, as is shown by the long-term
changes produced not only by prenatal
and postnatal stress (62,63) but also by
nonstressful manipulations, such as varia-
tion oflitter gender composition (64,65).
The interest for behavioral toxicology
and teratology ofthese plasticity phenom-
ena has been considerably enhanced by
recent information concerning underlying
mechanisms. In fact, hyperalgesia has been
shown both in NGF-treated adult mice
(66) and in transgenic mice that make
excess NGF and have overgrown sympa-
thetic neurons that make contact with sen-
soryneurons [Davis et al., unpublished data;
(67)]. Therefore, changes in the dynamics
ofgrowth factors should be considered
when a toxicological profile includes
modifications in pain sensitivity.
Without attempting a review of the
literature on the effects ofearly treatments,
it must be mentioned that several experi-
ments have shown short- and long-term
effects ofprenatal and postnatal treatments
with opiate drugs (particularly morphine
and methadone) on pain reactivity and
responses to analgesics, including opposite
effects on sensitivity to morphine (68-71).
One of these studies has documented an
interaction in rats between treatment and
sex (that is, morphine hypersensitivity in
males and hyposensitivity in females) with
tests performed an extended period oftime
after the termination of morphine treat-
ment on postnatal days 1 to 7. Moreover,
the specificity of these effects was sup-
ported by the finding that both opioid
stress analgesia after intermittent cold-
water swims and nonopioid analgesia after
continuous swims were little affected by
the earlytreatment (70).
The literature on other potential behav-
ioral teratogens is more scattered but con-
tains some interesting indications; for
example, the analgesic effect ofmorphine
was found to be enhanced by exposure to
lead throughout pregnancy and lactation
(72). On the other hand, as emphasized in
a previous section, negative data like those
concerning the development ofmorphine
analgesia after prenatal benzodiazepine
treatment can provide a useful contrast
when attempting to understand the mecha-
nisms ofproduction ofother treatment
effects (35).
Spontaneous MotorActivities
Innumerable combinations can be found in
the literature ofactivity test types and sub-
types, test conditions, test schedules, and
other local paraphernalia that are treasured
in any respectable behavioral laboratory.
A considerable portion ofthese test situa-
tions originally evolved to meet the need
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for neuropsychopharmacological assess-
ments (73,74), offering an ample choice
when behavioral teratology assessments
were started in relatively recent times.
On the other hand, as shown by the
representative examples given in a previous
section, the profile ofearly treatment effects
on motor activity can show considerable
variation as a function oftest type and test
conditions. Moreover, treatment-test inter-
actions have a perverse tendency to escalate
into higher order interactions whenever
othervariables are also considered, e.g., ani-
mal strain, sex, and age oftesting, to men-
tion only some ofthe more important ones.
The aim ofthe present section is there-
fore to provide basic information concern-
ing activity tests that have proved effective
in detecting developmental effects oftoxi-
cological interest as well as testing strategies
that are likely to minimize the risk ofboth
false positives and false negatives.
General Indicatfons forthe Use
ofActivityTests
As already mentioned, the range ofavail-
able motor activity tests is so wide that it
would be arbitrary to propose a hierarchy
ofcost-effectiveness ratios aimed at orient-
ing test choice. Some general indications,
however, can be given here concerning
either requirements that need to be fulfilled
or test conditions from among which the
experimenter must make choices related to
research goals and available resources.
First, an obvious requirement is the
reproducibility ofresults both within labo-
ratories (hence the importance ofbuilding
a database ofhistorical controls that serves
to locate anomalies in individual experi-
ments) and between laboratories. Experi-
menter biases are more easily minimized by
the use ofautomated versions of activity
tests, several ofwhich are commercially
available. On the other hand, some advan-
tages of nonautomated tests, especially
those designed to allow the scoring of
several responses from videorecordings, can
be more pronounced in activity assess-
ments than in other types ofassessments.
This applies in particular to treatments that
tend to produce a mixed bag of response
enhancements (stimulation) and response
reductions (depression), i.e., effect profiles
not easily assimilable to those ofreference
agents, at least when the trend ofdose-
response functions is considered.
Second, the choice ofappropriate ages
for activity testing must be based on
the normal developmental pattern, which
indudes widely differing activity profiles at
successive ages. In altricial species like the
rat and the mouse, whose offspring are
highly immature at birth, the activity level
is low for 10 or more postnatal days and
then increases rapidly around or shortly
after the end ofthe second postnatal week
(i.e., in relation with eye and ear opening).
The typical adultlike habituation pattern-
namely, the response reduction either at
successive times during a single test of at
least 30 min duration (within-session
habituation) or in successive tests (between-
session habituation)-emerges only several
days later (at about the time ofweaning
around the end of the second postnatal
week or even after one or two additional
weeks, depending on the strain or the test
used). Since the phenomena just mentioned
provide useful information on the develop-
ment ofseveral important regulatory mecha-
nisms (monoaminergic, cholinergic, etc; see
the example ofprenatal benzodiazepine
effects in the section "Inference Strategies,
Research Goals, and Resources"), activity
should be tested at three successive ages:
shortly after the activity increase related to
eye and ear opening, shortly after the time
when controls first show a typical aduldike
habituation pattern, and at the young adult
stage, i.e., after sexual maturation. The use
ofthe same animals at different ages is obvi-
ously more economical than the use of
naive animals at each age. Test experience,
as is well known, can influence subsequent
performances; however, data suitable to
determining whether early treatment effects
can be substantially affected by repeated
testing are apparently not available.
Third, a choice must be made oftesting
time relative to the circadian illumination
cycle. Both rats and mice are predomi-
nantly nocturnal species and therefore show
higher activitylevels duringperiods ofdark-
ness than duringlight periods; in relation to
its smaller body size, however, the mouse
has more frequent bouts of activity, feed-
ing, and drinking during light hours than
the rat. Experiments are generally per-
formed during regular working hours, i.e.,
during the light period when the normal
light-dark cycle is used in animal and test
rooms (which is apparently the case in the
majority ofpublished experiments), or, vice
versa, during the dark period ifthe cycle is
reversed. Direct comparisons between the
effects oftreatments ofbehavioral teratolog-
ical interest under the two conditions have
apparently not been performed. According
to our experience, reversedcycle conditions,
which allow us to test animals during the
dark period without requiring a reversal of
the experimenters' circadian cycle, are
preferable to other conditions. During this
period, small rodents show higher baselines
ofoverall activity and a fuller display of
various components of their repertoire,
which improves the quality of the data
when the scoring ofmore than one or two
responses is desirable.
In this context, it is recommended that
at least an approximate balance be achieved
between experimental groups in the assign-
ment ofanimals to different times oftesting
within the chosen period. In fact, activity
levels tend to fluctuatewithin both the light
and dark periods; bouts ofhigh activity, for
example, are more frequent during the ini-
tial than during the later portions of the
dark period, which can fake stimulating or
depressant effects ofa treatment ifbalanc-
ingfor time oftesting is not performed.
Fourth, activity profiles and treatment
effects thereon can be influenced by the
greater or lesser familiarity ofthe test envi-
ronment, if nothing else because of the
effects of habituation and different
amounts ofstress involved (for some exam-
ples drawn from behavioral teratology stud-
ies, see the section "Inference Strategies,
Research Goals, and Resources"). At the
two opposite extremes, a home cage test
provides the most familiar enviroment, and
an exposed test area such as the open field
arena provides the most unfamiliar envi-
ronment. Any test, however, can be used
both ways; the open field, for example, can
become a highly familiar environment after
prolonged or repeated exposure, while the
home cage can be turned into an unfamil-
iar environment when the rat or mouse is
shifted from a social to an isolated condi-
tion (as is usual) and the cage is freshly
cleaned and furnished with clean bedding.
Most activity data are parametric and
therefore amenable to statistical analyses
that range from comparisons between two
groups by the Student's t-test to analysis of
variance (ANOVA) designs of increasing
complexity (75). Under the condition of
having access to expert statistical advice
and appropriate software, mixed-model
ANOVA designs have special value in the
analysis ofparametric data from behavioral
teratology experiments, not being subject
to the limitations ofnonparametric analy-
ses. Provided that they are balanced (since
unbalancing imposes the use ofspecial, bur-
densome procedures), mixed-model
ANOVA designs can cope with any combi-
nation offixed factors (such as treatment,
sex, etc.) and random factors (such as litters
within each treatment-test age combination
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and subjects within each final group under-
going repeated testing). Without having to
bother with the algebra and computational
procedures, an experimenter needs only
limited training to grasp the meaning of
various effects and interactions and to learn
to locate their sources by the minimal num-
ber ofbetween-group comparisons within
logical sets ofmeans.
Clarity of statistical inferences and
minimization of both type I and type II
errors (false positives and false negatives,
respectively) are thus achieved much more
effectively than by the repetitive application
ofapparently simpler procedures to large
databases with many group and subgroup
means. The frequency offalse negatives,
which can be quite costly and highly mis-
leading in experiments oflong duration, as
is the case in behavioral teratology, can be
further reduced by the adoption ofa post
hoc test such as Tukey's test, whose applica-
tion is permissible (or even recommended)
in the absence ofsignificant ANOVAresults
(76). In fact, Ftests on main effects and
interactions can often be blind to meaning-
ful deviations ofa limited number ofmeans
from the overall average within a logical set
ofmeans; therefore, the experimenter, who
is well acquainted with the nature ofthe
data, rather than the statistics advisor, must
learn to single out instances in which nega-
tive ANOVA results are highly likely to
constitute type II errors and to identify
significant between-group differences by
appropriate posthocs.
In the case of multiple response vari-
ables, separate univariate analyses performed
on individual end points are indicated and
mostly sufficient to characterize the effect
profile. However, the proliferation ofuni-
variate analyses on data from the same
experiment with several response end
points increases the risk ofspurious statisti-
cal significance (i.e., false positives); there-
fore, one should discount isolated instances
ofANOVA Fs and post hoc test values
above the p cut-off point chosen apriori.
Specifically, the expectation is to obtain an
average ofone such value out of20 tests, in
the absence ofany real effect, ifthe cut-off
point isp=0.05.
Given the scope ofthe present review,
no attempt can be made to discuss when
and how to escalate from univariate to
multivariate analyses in experiments with
multiple response end points. The experi-
menter performing first-tier risk assessments
must know that the data obtained in these
studies can gain considerable additional
value when the statistical advisor is able to
single out databases whose features make
multivariate analysis worth the additional
burden (to be borne by the advisor, of
course, not by the experimenter). In fact,
the art ofcharacterizing and comparing
effect profiles produced by behavioral tera-
tology studies is still in its infancy. There-
fore, the experimenter involved in first-tier
risk assessments on poorly known agents is
an ideal provider ofnew and original data-
bases that can serve to verify the value of
alternative multivariate models for the pur-
pose ofsubsequent standardization.
OpenField
The open field is a typical all-purpose
observational test, which imposes a consid-
erable workload; therefore its cost-effective-
ness ratio depends jointly on labor cost and
the value attached to information provided
by multiple response end points. The test is
performed in a circular orsquare arenawith
a washable floor that needs to be thor-
oughly cleaned after each test. The size of
the arena must be adjusted to both animal
species and age. In the case of mice, for
example, we now use a square (40x40 cm)
arena for 10- to 30-day-old subjects (77).
In the case ofrats, a typical size is 60x60
cm, which has proved suitable for testing
animals ofdifferent ages (78).
Whatever species and test conditions
are used, open field tests must be per-
formed under closely controlled conditions
ofillumination, background noise, and lay-
out oflandmarks outside the arena (e.g.,
the room furniture, any other object of
more than minimal size, and the experi-
menter's location). As in any observational
test, experimenter bias in the scoring of
various responses must be closely con-
trolled whether the scoring is made directly
during the test or later on, from video-
recordings. The ideal situation is to have
two observers, both blind to the animal's
treatment condition (although unavoidably
not to other conditions such as age and
sex) and to the fellow observer's scoring. In
research teams with adequate experience,
these precautions can be somewhat relaxed
ifthe reliability ofeach observer is verified
by periodic checks, but blindness to treat-
ments remains essential. Blindness, how-
ever, may prove impossible when early
treatments produce stunting or other visi-
ble effects; the same applies to pretest phar-
macological challenges (drug vs vehicle),
since agents producing typical behavioral
effects must be used.
One measurement that is always taken
in open field tests is that of locomotor
activity (deambulation); squares are drawn
on the floor (of 8x8 cm and 12x 12 cm,
respectively, in the mouse and the rat are-
nas mentioned above), and the number of
crossings between adjacent squares are
counted. The assessment ofactivity trends
as a function ofprolonged or repeated
exposure (generally in the direction of
response decrements, or habituation) is at
least as important as that ofoverall activity
levels, particularly when comparing succes-
sivedevelopmental phases. In fact, asalready
mentioned, trends over age ofoverall activ-
ity and ofhabituation are ontogenetically
dissociated from each other. In this respect,
it should be noted that the two types of
habituation-namely, that occurring during
the same extended exposure (within-session
habituation) and that occurring between
successive exposures, generally at 24-hr
intervals (between-session habituation)-
are not identical phenomena and are likely
to be served by neural mechanisms that are
at least partly separate from each other. The
strongest evidence on this point has been
provided by ontogenetic dissociations con-
sisting ofage-dependent differences both in
habituation trends and in d-amphetamine
and scopolamine effects, depending on
whether rats were given a single 30-min
open field test or three 5-min tests at 24-hr
intervals, with all other conditions being
equal, including the use ofdifferent animals
for tests at different ages (78).
As concerns the scoring of responses
other than locomotor activity and the use of
multiple response data, the list ofpotential
end points is a fairly long one, including
locomotion (crossings between squares),
rearing (wall rearing and nonsupported),
grooming, exploratory sniffing, freezing,
time spent lying still (without freezing),
time spent in contact or not in contact with
the walls, various stereotypes (i.e., increase
to above a zero or very low control level of
acts such as face washing, gnawing, circling,
jumping, head scanning, and focused
sniffing), digging and push digging (ifthe
floor is covered with bedding material),
urination, and defecation.
Ifresponses are scored during the test,
no more than three to four ofthem should
be included in the protocol to minimize
the risk ofobserver errors; the suggestion is
to focus the attention on locomotion, rear-
ing, grooming, and stereotypies that can
reveal noxious effects of the treatment
under study or must be scored as part ofa
pharmacological reactivity assessment [see
Laviola et al. (79) for normative data on
d-amphetamine effects in mice at different
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developmental stages]. In fact, these end
points generally suffice to verify whether a
treatment produces qualitatively or quanti-
tatively different effects depending on the
response variable.
Ifthe scoring is performed on video-
recordings, any number ofresponses can be
considered. A high number ofend points
however, can create considerable problems
in both data analysis (by increasing the bur-
den as well as the risk ofspurious statistical
significance) and data interpretation (for
the exploitation ofdatabases in subsequent
multivariate analyses, see the previous sec-
tion). In first-tier analyses, it is preferable to
limit the number of response variables to
the minimum that appears to be necessary
to characterize a profile ofmixed stimulant
and depressant effects, i.e., to avoid its con-
founding with either overall depression or
other mixed profiles, including thosewhich
are typical of psychostimulants such as
amphetamine and cocaine. In fact, uni-
form enhancement ofseveral responses that
are partly or totally incompatible with each
other (so-called response competition)
cannot occur, while the specific features of
a mixed profile can provide significant
information on the nature ofthe changes
produced by a treatment. For example, a
high frequency of grooming and stereo-
typed movements accompanying a reduc-
tion oflocomotion and rearing can point
to the need for biochemical and pathologi-
cal investigations aimed at identifying the
nature and location ofsubcortical changes.
ActivityinClosedTestEnvironments
Many tests are in use for the assessment of
activity in closed environments. These
range from a thoroughly familiarhome cage
with the animal's own soiled bedding (but
generally with a shift from a grouped to an
isolated condition for the time ofthe test)
to a variety ofless familiar situations, e.g.,
cages and boxes ofquite different shapes
and sizes. No particular version ofthis type
of test can be considered superior to others
so as to deserve to be recommended and
described in detail.
Most ofthe tests we considered are used
with automated recording ofresponses that
exploits physical events such as movement
ofthe floor, vibration ofthe cage or box,
interruption ofphotocell beams, and alter-
ation oflow energy radio frequencies. In
most types ofcommercial and noncommer-
cial automated apparatus, appropriate
adjustment ofthe location and sensitivity of
the sensors can allow the experimenter to
record two types ofmovements-i.e., one
in the horizontal plane (locomotion) and
the other in the vertical plane (generally
rearing)-and also to pick up gross neuro-
logical symptoms such as tremor. In many
instances, this arrangement can suffice to
reduce bias in the assessment ofa variety of
treatment effects on activity that either can
consist of different (or even opposite)
changes in the two types ofresponses or can
be secondary to neurological manifesta-
tions. The risk of confounding between
quite different behavioral syndromes, how-
ever, is not entirely eliminated. The classic
example in psychopharmacology is that of
the similar scores provided by an automated
apparatus that measures only ambulation
and rearing after treatment with neurolep-
tics, various sedatives, tremorogenic agents,
various kinds ofcholinergic agonists, and
high (stereotypy-inducing) doses ofmono-
aminergic stimulants such as amphetamine.
Therefore, observational versions ofthe
tests may have to be considered when it
appears desirable to analyze treatment effects
on a wider range ofresponses; this is best
achieved by scoring from videorecordings
taken through a transparent wall ofthe box
or cage. Observation is also needed when
testing of nonisolated animals is desirable
to characterize the social interaction com-
ponents ofthe repertoire during develop-
ment, particularly after early exposure to
agents whose effects on social responses are
documented in the adult (80).
Activity assessments are also performed
in test environments with greater complex-
ity and more elaborate scoring systems that
consider both different responses and dif-
ferent sequences ofthe same response. For
example, extensive use has been made- of
the Figure-8 maze, which consists ofseveral
interconnected alleys forming the figure and
intended to mimic the burrows ofthe rat's
natural habitat (81). This test environment,
which tends to elicit high levels ofsponta-
neous motor activity, has been exploited in
several studies, including the Collaborative
Behavior Teratology Study (22). In the
Collaborative Behavior Teratology Study,
the profiles ofprenatal treatment effects on
activity were assessed by testing at different
ages and for different durations (including
responses to an amphetamine challenge);
these profiles have shown considerable vari-
ation among different laboratories, particu-
larly in prenatal d-amphetamine treatment
conditions. Comparable attempts to ana-
lyze interlaboratory variation in the results
of other activity tests are not available;
therefore, the variability ofFigure-8 maze
results in the study just mentioned should
not be construed as an indication against
the further use ofthis test.
Other tests also exploit complex envi-
ronments, as is the case with the hole-
board test, which is aimed at separating
activity (mainly locomotion) from explo-
ration (dipping the head into the holes
drilled in the cage floor). This and other
similar distinctions are essentially anthropo-
morphic ones and fail to provide adequate
cues to the understanding of response-
related differences in treatment effects,




This section provides a selection ofrepresen-
tative treatment effects and interactions
(with test factors per se on one side and
organismic factors such as animal strain, sex,
and age oftesting on the other), including
information on responses to drug challenges
after treatments at early developmental
stages (35,82-85).
A preliminary consideration is that,
before any behavioral teratology study,
developmental trends of activity and
responses to drug challenges need to be
assessed and verified for replicability more
thoroughly than other end points that have
a lesser tendency to vary, like those illus-
trated in the section on postnatal sensory
and motor development. Later on, repeated
cross-checks between controls in a particu-
lar experiment and in previous experiments
(historical controls) are equally essential. In
fact, several data document both reassuring
analogies between developmental trends in
the presence ofpotentially strong sources
of variation and unexpected deviations
from apparently well-established develop-
mental profiles.
At one extreme, for example, five
inbred mouse strains with quite different
activity profiles were shown to be highly
uniform with respect to the appearance of
antimuscarinic (scopolamine) hyperactivity
at the end of the third postnatal week
(86). In my group's experience, some phe-
nomena, like the simultaneous appearance
in mice of habituation and scopolamine
hyperactivity have been observed over and
over again, under both the same and quite
different conditions, such as repeated brief
exposures to the open field (yielding
between-session habituation) and a single
extended exposure to a house cage made
unfamiliar by clean bedding (yielding
within-session habituation).
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At the opposite extreme, the experi-
menter can be faced with unexpected disso-
ciations between developmental events that
in several previous experiments had always
been closely related to each other in spite of
differences in species and test conditions.
For example, in an experiment using differ-
ent test schedules in the same open field, rat
pups exposed to a single 30-min session
showed only minimal within-session habitu-
ation at 3 weeks and full-fledged habitua-
tion at 4 weeks; at the latter time, however,
scopolamine was still without effect and
full-fledged drug hyperactivity was found
only 2 weeks later. Even more surprisingly,
exposure to three brief (5-min) sessions at
24-hr intervals allowed a near-complete
between-session habituation to appear at 3
weeks, but no scopolamine effect was seen at
3, 4, or 6 weeks (78).
Previous data had indicated that the
maturation ofscopolamine effects on other
responses could occur much later than that
of its effects on locomotor hyperactivity
(87). However, the data now available on
the age- and test-dependent effects of
this and other drug challenges, particularly
amphetamine (78), strengthen the notion
that the response factor can account for only
part of the observed variation in develop-
mental activity profiles and drug reactivity.
This indicates two things: the matura-
tion of a given neural mechanism can be
revealed by the earliest age at which a stim-
ulant or an antimuscarinic treatment pro-
duces marked locomotor hyperactivity, but
functional reliance on the same mechanism
for the modulation of the same response
under different conditions (or of other
responses) can develop only later. Ontoge-
netic dissociations of the two types of
phenomena probably depend on the devel-
opmental pace ofother interacting mecha-
nisms whose role varies from one situation
to the other.
This tentative model can help us under-
stand the maturation phenomena exploited
in behavioral teratology studies, which are
related to specific new needs ofthe develop-
ing organism each time it moves on from
one ecological niche to a new one (in the
case ofaltricial rodents, for example, at the
time ofeye and ear opening and at the time
ofweaning). The methodological implica-
tions are not only for higher tier studies but
also to first-tier risk assessments, for reasons
ofefficacy and economy. In fact, the experi-
menter should verify that the chosen com-
binations of activity test conditions and
drug challenges are suitable for picking up
critical developmental events at the time of
their earliest possible occurrence, such as
an activity surge and an increase in sensitiv-
ity to monoaminergic psychostimulants
around the end of the second postnatal
week and the appearance ofadultlike habit-
uation and scopolamine hyperactivity about
1 week later. In fact, any treatment effect on
the development ofthe neural mechanisms
responsible for these changes could be
missed if test conditions delay the onset of
functional reliance on these mechanisms
and the changes produced by the treatment
under study tend to be attenuated as the
animal grows older.
Another methodological implication
involves some important gaps in our
knowledge concerning early treatment
effects on developmental trends of drug
reactivity. Specifically, several behavioral
teratology studies have verified that useful
information can be obtained by the use of
monoaminergic drugs (particularly amphet-
amine, apomorphine, and cocaine), cholin-
ergic-muscarinic agonists and antagonists,
opiatergic drugs, and benzodiazepine
receptor ligands. By contrast, the proper-
ties ofother classes ofagents have not yet
been effectively exploited; the most obvi-
ous example is represented by 5-HT ago-
nists and antagonists, whose effects at
successive developmental stages have been
carefully studied (88,89). This may be due
to the fact that the wide range oftypes and
subtypes in these drug classes makes it
difficult to effect a rational choice of a
highly restricted number ofdrug challenges
under the constraints ofbehavioral terato-
logical assessments.The most obvious of
these constraints is the need to have all chal-
lenges and appropriate controls represented
within each litter in each treatment-test age
combination, in order to avoid the con-
founding oftreatment andlitterfactors.
Overall, the increasing diversification
within all classes of model drugs awaits
exploitation in a more thorough analysis of
early treatment effects and mechanisms of
action on the basis ofnormative data con-
cerning psychopharmacological reactivity
duringdevelopment; the effectiveness ofthis
analysis is shown, for example, by the differ-
ent effects ofselective p-, k-, and &-opioid
agonists in neonatal rats (90). The nature of
the interactions observed when studying
early treatment effects on activity and drug
reactivity can be further illustrated by the
data concerning two well-known neurotoxi-
cants, MM and ethanol, and an environ-
mental pollutant, 03, which is devoid of
major neurotoxic effects but can produce
subtle and selective behavioral changes.
Methylmercury (MM). As early as
1978, Hughes and Sparber (91) showed
that, in the absence ofprenatal MM effects
on operant response levels (essentially
a measure of spontaneous activity) and
on acquisition of an autoshape task,
MM subjects showed an attenuation of
the disrupting amphetamine effects on
autoshaped behavior.
In a series ofstudies byAnnau, Cuomo,
and co-workers (92-94), rats were given 5
to 8 mg/kg MM (po) on day 8 or 15 of
pregnancy; open field activity at various
postnatal ages was apparently not affected.
The role of test factors, however, is sug-
gested by the results ofanother study in the
same series (95), which showed hyperactiv-
ity at 4 to 15 days with a different test using
a closed activity cage. More importantly, the
former studies showed an enhancement of
amphetamine hyperactivity in the open field
and an enhancement ofboth apomorphine
sniffing and apomorphine depression of
activity in the MM offspring. These effects
tended to become attenuated after the sec-
ond or third postnatal week and were
related to an increased density ofdopamine
receptors, whereas clonidine effects on activ-
ity and the profile of cortical 2-adreno-
receptors were not modified.
In the Collaborative Behavior Teratol-
ogy Study (22), involving six laboratories,
there was more variation in the effects of
prenatal MM (2 or 6 mg/kg po on gesta-
tional days 6-9) on Figure-8 activity, which
was assessed at different ages and by tests
with different durations, than in the effects
on other end points, particularly auditory
startle habituation. Nevertheless, there was
an overall significance of two fairly consis-
tent effects, namely, increased Figure-8
maze activity in 1-hr tests and enhancement
ofthe hyperactivity response to an amphet-
amine challenge.
Overall, the profile of MM prenatal
effects on activity of the offspring and
response to amphetamine appears to be ade-
quately verified across laboratories and tests
and consistent with the observed changes in
dopamine receptors.
Ethanol. The effects of early (particu-
larly prenatal) ethanol exposure on subse-
quent activity have been extensively
investigated and have yielded fairly consis-
tent results. In fact, several studies have
shown hyperactivity in the treated offspring
at different ages and with different tests
(96-101), although some negative findings
have also been reported (29,102). Because
the latter study (102) was aimed mainly at
the assessment of behaviors other than
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activity, separate and combined the effects
ofprenatal and postnatal exposure were
assessed in artificially reared rat pups.
The nature ofethanol effects has also
been extensively investigated by the use
of drug challenges. In several of the
experiments mentioned above (97-100),
responses at successive postnatal ages to
d-amphetamine, alpha-methyl-p-tyrosine,
p-chlorophenylalanine, and methysergide
were apparently not modified, whereas the
appearance ofphysostigmine depression and
scopolamine hyperactivity was markedly
delayed. It was concluded that the basic
change produced by prenatal ethanol expo-
sure was a delayed maturation of those
cholinergic-muscarinic mechanisms that are
deemed to modulate activity levels by
counterbalancing the excitatory function of
other (mainlymonoaminergic) mechanisms.
Other data, however, contradict at
least in part the inferences just mentioned.
In one study, for example, ethanol-treated
offspring showed an enhanced ampheta-
mine hyperactivity (103); in another
study a similar sensitization was found
with a methylphenidate challenge (104).
In addition, a dose-response shift to the
left for locomotor activity has been found
in ethanol-treated rat offspring with
apomorphine (105).
In the first ofthese studies (103), males
at 4 weeks ofage dearlyshowed the change
in amphetamine reactivity but females did
not; this is ofconsiderable interest in the
light ofthe growing evidence on early sex
dimorphism ofmonoaminergic regulatory
systems (79). Moreover, the same study
achieved a separation of the effects of
ethanol from those of an important con-
founding variable by the use of a yoked
control group that received sucrose substi-
tuted isocalorically for ethanol. Specifically,
the ethanol enhancement ofamphetamine
reactivity in 4-week-old males failed to
occur in theyoked group, whereas both the
ethanol-treated and the yoked animals of
both sexes showed a reduced amphetamine
response at 6 weeks ofage.
Considering the extraordinary impor-
tance of adequately understanding the
developmental effects ofsubteratogenic
doses ofethanol, the data mentioned so far
are ofconsiderable interest. In spite ofthe
numerous discrepancies whose sources have
not yet been located, they provide a basis
for planning further experiments aimed at
identifying the combinations oforganismic,
treatment, and test factors that facilitate or
prevent the behavioral expression of
changes in regulatory mechanisms.
Some interesting indications are already
available concerning possible interacting
variables, particularly considering that
the various activity tests involve different
degrees offamiliarity and different amounts
of stress. For example, stress responses
(grooming) were enhanced in ethanol-
treated offspring after a forced swim but
not after exposure to aless stressful environ-
ment. Moreover, when the less stressful
exposure preceded the forced swim, the
ethanol effect on swim-induced grooming
disappeared; in addition, naloxone reduc-
tion ofgroomingwas not modified (106).
Ozone (O). Although 03 is known
mainly for its adverse effects on the respira-
tory system, it can also produce other types
ofsomatic effects, e.g., on immune func-
tions (107). Exposure to 03 can cause
behavioral disturbances in humans, such as
impairment ofvigilance level and decreased
physical performance and can depress sev-
eral responses in adult rats and mice, such
as locomotion, feeding and drinking, and
operant responding (40,108). Late-gesta-
tional exposure of rats to 03 (pregnancy
days 17-20, 1.0-1.5 ppm) has been shown
to impair somatic and neurobehavioral
development ofthe offspring, including a
delay in the maturation of reflexes and
responses such as righting, grooming, and
locomotion in an open field (109); how-
ever, cross-fostering procedures aimed at
ruling out postnatal maternal effects were
not used in this study. A more recent
experiment in mice, which included these
procedures, failed to show any effect of
mid- and late pregnancy 03 exposure (days
7-17, 0.4-1.2 ppm) on either postnatal
neurobehavioral development or activity,
habituation, and response to amphetamine
at 60 days; the responses were assessed by
an automated unfamiliar-home-cage test
suitable to yielding high initial activity
scores followed by response reduction (40).
Subsequent studies in mice used more
prolonged 03 exposure, up to 0.6 ppm,
from several days before the start ofpreg-
nancy until either day 17 of pregnancy
(110) or weaning ofthe offspring 3 weeks
after birth (77), with or without cross-fos-
tering at birth, respectively. Both exposure
schedules again failed to affect postnatal
neurobehavioral development, in spite ofa
marked and long-lasting depression ofpost-
natal body weight gain in the study with
combined gestational and postnatal treat-
ment. The offspring exposed prenatally but
not postnatally also failed to show changes
inyoungadult activity orhabituation in the
automated test mentioned above. However,
observational social interaction tests per-
formed at 23 to 25 and 43 to 45 days on
paired animals in the same test environment
showed significant changes in response
profiles; these consisted mainly ofa reduc-
tion oflocomotion and other exploratory
movements (such as rearing and sniffing at
the air, the walls, or the sawdust on the
floor), which was paralleled by a significant
increase in self-grooming. By contrast, sev-
eral responses directed to the partner (such
as sniffing, following, grooming, etc.) were
not affected byprior 03 exposure (110).
The effects ofcombined gestational and
postnatal exposure on response profiles in
two different observational tests and an
automated test were more pronounced but
equally selective (77). An open-field test
(40x40 cm arena) at 24 days in 03-
exposed mice showed an attenuation or
elimination ofsex differences, i.e., a reduc-
tion ofthe higher female scores to male lev-
els in the case ofrearing and a convergence
ofboth female (lower) and male (higher)
scores toward the overall average in the case
ofsniffing. The marked response changes
produced by an antimuscarinic challenge
(scopolamine 2 mg/kg) were not modified.
The second open-field test at 29 days,
performed in a smaller arena (16x 15 cm)
using the mice that had received the saline
(control injection) in the previous test,
showed only an 03 reduction in grooming.
(Note that this effect, opposite to that
observed after gestational but not postnatal
exposure, was obtained in conditions quite
different from those ofthe previous experi-
ment-namely, in an open field rather than
a closed environment, and in subjects with
prior experience tested individually rather
than in naive subjects tested in same-sex
pairs.) The marked effects on various
responses produced by a psychostimulant
challenge (d-amphetamine, 3.3 mg/kg)
were essentially unmodified. (Some iso-
lated instances ofstatistical significance had
to be discounted when taking into account
the number of comparisons performed.)
Treatment-sex interactions could not be
adequately evaluated in this experiment
since there were only four subjects in each
combination of prior exposure, sex, and
pretest treatment.
The third activity assessment exploited
the final test exposure at 31 days ofage on
a conditioned place preference (CPP)
schedule that included a single 3.3 mg/kg
d-amphetamine treatment 2 days before;
naive littermates ofthe subjects in the two
previous tests were used, and activity was
recorded by photocells located in the CPP
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apparatus (essentially a rectangular 40x 15
cm, 3-compartment open field). Ozone-
treated mice showed a disappearance ofthe
sex difference in overall activity, with the
03 males' scores being significantly higher
than those of the controls and similar to
those ofcontrol and 0 females, which did
not differ from each other.
Overall, the effect profiles observed in
the various situations with the different
schedules of 03 exposure appear to have
the following methodological implications.
First, these data, most ofwhich essentially
belong to first-tier risk assessments in the
absence of previous appropriate studies,
show that a considerable amount ofinfor-
mation can be obtained by these assess-
ments, i.e., prior to any higher tier study.
The overall test burden was fairly large but
quite reasonable relative to the burden cre-
ated by the nature of the treatment (03
being a highly unstable molecule that
requires considerable technical parapherna-
lia to maintain controlled concentrations),
by the need to use different concentrations
and durations of exposure, and by the
maintenance ofthe animals.
Second, some significant 03 effects on
activity, such as the attenuation or elimina-
tion of sex differences, were picked up by
quite different versions of the same test,
namely, a conventional square open field
with scoring from videorecordings of the
responses ofnaive animals, and a rectangu-
lar 3-compartment open field with auto-
mated recording of the responses of
experienced animals. (Ofcourse, the use of
the CPP apparatus is not recommended for
routine activity testing, but in this experi-
ment the recording ofactivity in the final
session of the CPP schedule-clearly a
higher tier test-provided additional data
practically gratis).
Third, the failure to locate treatment-
sex interactions in the second observational
test warns against an excessive reduction of
final group size. In fact, as is well known,
the power ofANOVA Ftests on interac-
tion effects is much less than that ofFtests
on main effects; furthermore, post hocs
on differences between the means offinal
groups cannot circumvent this obstacle
when the number ofdegrees offreedom is
strongly reduced.
Fourth, the negative results, including
the absence of significant changes in
reactivity to different drugchallenges, appar-
ently rule out major orwidespread neuroter-
atogenic effects of the pollutant. On the
other hand, the selective response changes in
different activity tests were suitable to
generate specific working hypotheses con-
cerning possible mechanisms ofthe treat-
ment's action. Specifically, the attenuation
ofsex differences bears a strong similarity
to that observed after developmental expo-
sure to a wide variety ofstressors, which
suggests that 0 may produce long-lasting
neural and endocrine changes like those
documented by studies on early stress
effects (77,110); this in turn could account
for selective medium- and long-term
behavioral changes in the absence ofdirect
neuroteratogenic effects.
The data available so far cannot indi-
cate whether the changes produced by 03
exposure resulted from a direct effect on
the fetus and the newborn or were the
consequence of somatic and behavioral
changes in the dams; these data, however,
suffice to reject the null (no effect) hypo-
thesis and to characterize developmental
03 exposure as a treatment with a possible
risk ofborderline neurobehavioral pathol-
ogy. The significance of this inference
obviously depends on both the sensitivity
of developing humans relative to that of
altricial rodent species and the number of
human subjects exposed to concentrations
of the same order of magnitude. As con-
cerns the latter, a well-known WHO meta-
analysis published in 1987 pointed to peak
03 concentrations often exceeding 0.2
ppm in large, polluted urban areas and to
lowest-observed-effect levels in the 0.08 to
0.2 ppm range (111). A more recent survey
in the Paris area showed that 0.05 ppm can
produce a significant increase in the fre-
quency and severity ofrespiratory illnesses
in children (112); however, information
concerning neurobehavioral development
of exposed children is apparently not
yet available.
Conclusion
This review has attempted to provide both
general and specific indications for the
effective use ofeconomical test methods in
behavioral teratology assessments; in paral-
lel, an attempt has been made to discuss
the nature ofthe information that can rea-
sonably be expected when using one or the
othier test strategy.
Some tests, particularly functional
observational batteries that can exploit the
regularity in postnatal development ofsev-
eral reflexes and responses, have been stan-
dardized and validated to the point that
their use can be strongly recommended
both in proactive studies performed prior to
any human exposure and in reactive stud-
ies. Other tests, particularly those aimed at
assessing motor/exploratory activities, have
been and continue to be used in many dif-
ferent versions, often resulting in different
profiles oftreatment effects as a function of
age at testing and othervariables.
In spite ofthis variation of treatment
effects, behavioral teratology is coming
close to defining the conditions that are
most suitable for risk assessment in first-tier
proactive studies, with increasing control
over possible biases and confounding vari-
ables and therefore a progressive abatement
of the probability of both false negatives
and false positives. In this context, differ-
ences in treatment effects as a function of
other variables should not be discounted as
pure noise or as a nuisance. In fact, they
often provide useful preliminary informa-
tion on treatments' mechanisms ofaction.
In addition, they help in evaluating the
functional significance of different CNS
changes assessed by neurobiological meth-
ods (e.g., in receptor profile, enzyme activ-
ity, or neurotransmitter metabolism),
which are otherwise difficult to interpret.
This applies in particular to ontogenetic
dissociations, i.e., differential treatment
effects depending jointly on developmental
stage at the time ofexposure, age oftesting,
and response end point.
On the other hand, appropriate reactive
studies appear to have special value when
there is a risk that chemical exposures
result in borderline pathology among large
cohorts ofdeveloping human subjects in
the absence ofhard clinical and pathologi-
cal evidence ofneuroteratogenicity, as has
been shown to be the case with low doses
oflead and ethanol and with prenatal ben-
zodiazepine exposure. Specifically, animal
data can not only be a useful complement
to epidemiological and dinical-psychologi-
cal data that are already available, but can
also contribute to the rational designing of
further human studies. In fact, human stud-
ies have alongduration and ahigh cost, and
experimenters must avoid making random
choices among awidevarietyofpossible end
points and confounding variables. These
choices could be made miore effectively by
taking into account the indications provided
by animal experiments concerning behav-
ioral responses or repertoires and regulatory
mechanisms that are affected or unaffected
by aparticular treatment.
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